StockData
IN8bio, Inc. logo

IN8bio, Inc. (INAB) stock

INABNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.76−0.01 (-1.86%)

Close on Nov 20, 2026Market cap $7.47MP/E –Yield –

IN8bio gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for IN8bio

IN8bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More IN8bio figures

See a number that looks wrong?